PL4337029T3 - Suplement diety do stosowania jako środek wspomagający w zapobieganiu i leczeniu pogorszenia funkcji poznawczych związanego z chorobą alzheimera - Google Patents
Suplement diety do stosowania jako środek wspomagający w zapobieganiu i leczeniu pogorszenia funkcji poznawczych związanego z chorobą alzheimeraInfo
- Publication number
- PL4337029T3 PL4337029T3 PL22723773.2T PL22723773T PL4337029T3 PL 4337029 T3 PL4337029 T3 PL 4337029T3 PL 22723773 T PL22723773 T PL 22723773T PL 4337029 T3 PL4337029 T3 PL 4337029T3
- Authority
- PL
- Poland
- Prior art keywords
- alzheimer
- disease
- prevention
- treatment
- dietary supplement
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102021000012515A IT202100012515A1 (it) | 2021-05-14 | 2021-05-14 | Integratore alimentare, per uso come coadiuvante, per la prevenzione del declino cognitivo associato alla malattia di Alzheimer |
| PCT/IB2022/053781 WO2022238793A1 (en) | 2021-05-14 | 2022-04-22 | A food supplement for use as coadjuvant in the prevention and treatment of cognitive decline associated with alzheimer disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4337029T3 true PL4337029T3 (pl) | 2025-09-22 |
Family
ID=77022108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL22723773.2T PL4337029T3 (pl) | 2021-05-14 | 2022-04-22 | Suplement diety do stosowania jako środek wspomagający w zapobieganiu i leczeniu pogorszenia funkcji poznawczych związanego z chorobą alzheimera |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12514893B2 (pl) |
| EP (1) | EP4337029B1 (pl) |
| JP (1) | JP2024517354A (pl) |
| CN (1) | CN117425410A (pl) |
| CA (1) | CA3217534A1 (pl) |
| DK (1) | DK4337029T3 (pl) |
| ES (1) | ES3038954T3 (pl) |
| FI (1) | FI4337029T3 (pl) |
| HU (1) | HUE072692T2 (pl) |
| IT (1) | IT202100012515A1 (pl) |
| PL (1) | PL4337029T3 (pl) |
| PT (1) | PT4337029T (pl) |
| WO (1) | WO2022238793A1 (pl) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003003981A2 (en) * | 2001-07-05 | 2003-01-16 | Vital Basics, Inc. | Compositions for improving mental performance |
| US20040191334A1 (en) * | 2003-03-24 | 2004-09-30 | Pang-Chui Shaw | Use of transhinone derivates as cholinesterase inhibitors in treating related diseases |
| US8017147B2 (en) * | 2008-04-07 | 2011-09-13 | Mazed Mohammad A | Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance |
| EP2318025A2 (en) * | 2008-07-28 | 2011-05-11 | National Brain Research Centre | Withania somnifera plant extract and method of preparation thereof |
| BR112015002309A2 (pt) * | 2012-08-07 | 2017-07-04 | Buck Inst Res Aging | formulação de múltiplos componentes para aprimorar a função neurológica |
| US10596216B2 (en) * | 2015-03-23 | 2020-03-24 | Ethnodyne and Centre National de la Recherche Scientifique (CNRS) | Use of a Withania extract for the treatment of amyloid-related diseases |
| IT201900013707A1 (it) * | 2019-08-01 | 2021-02-01 | Cristalfarma S R L | Integratore alimentare, per uso come coadiuvante, per la prevenzione della demenza vascolare |
| TWI899096B (zh) | 2019-08-09 | 2025-10-01 | 日商三菱瓦斯化學股份有限公司 | 化合物、聚合物、組成物、膜形成用組成物、圖型形成方法、絕緣膜之形成方法及化合物之製造方法,以及含有碘之乙烯基聚合物及其乙醯化衍生物之製造方法 |
-
2021
- 2021-05-14 IT IT102021000012515A patent/IT202100012515A1/it unknown
-
2022
- 2022-04-22 WO PCT/IB2022/053781 patent/WO2022238793A1/en not_active Ceased
- 2022-04-22 FI FIEP22723773.2T patent/FI4337029T3/fi active
- 2022-04-22 CA CA3217534A patent/CA3217534A1/en active Pending
- 2022-04-22 PT PT227237732T patent/PT4337029T/pt unknown
- 2022-04-22 JP JP2023570369A patent/JP2024517354A/ja active Pending
- 2022-04-22 EP EP22723773.2A patent/EP4337029B1/en active Active
- 2022-04-22 PL PL22723773.2T patent/PL4337029T3/pl unknown
- 2022-04-22 US US18/289,779 patent/US12514893B2/en active Active
- 2022-04-22 ES ES22723773T patent/ES3038954T3/es active Active
- 2022-04-22 CN CN202280034791.2A patent/CN117425410A/zh active Pending
- 2022-04-22 HU HUE22723773A patent/HUE072692T2/hu unknown
- 2022-04-22 DK DK22723773.2T patent/DK4337029T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| FI4337029T3 (fi) | 2025-08-25 |
| CA3217534A1 (en) | 2022-11-17 |
| EP4337029A1 (en) | 2024-03-20 |
| CN117425410A (zh) | 2024-01-19 |
| HUE072692T2 (hu) | 2025-12-28 |
| DK4337029T3 (da) | 2025-09-01 |
| IT202100012515A1 (it) | 2022-11-14 |
| US12514893B2 (en) | 2026-01-06 |
| WO2022238793A1 (en) | 2022-11-17 |
| US20240285713A1 (en) | 2024-08-29 |
| PT4337029T (pt) | 2025-08-21 |
| JP2024517354A (ja) | 2024-04-19 |
| ES3038954T3 (en) | 2025-10-16 |
| EP4337029B1 (en) | 2025-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWD193694S (zh) | 口腔保健用具(二) | |
| ZA200802897B (en) | New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of Alzheimer's Disease | |
| MX2007005723A (es) | Articulos para tratamiento que pueden amoldarse a una forma subyacente. | |
| ES2414872T8 (es) | Terapia combinada para la prevención o tratamiento de la enfermedad de Alzheimer y kit correspondiente | |
| EA200500399A1 (ru) | Ненуклеозидные ингибиторы обратной транскриптазы | |
| IL289167A (en) | The history of 2h-indazole and their use in the treatment of diseases | |
| IL308152A (en) | 2-fluoroalkyl-4,3,1-oxadiazol-5-yl-thiazole, HDAC6 inhibitors for use in the treatment of metabolic disease and HFPEF | |
| IL307763A (en) | Glucanolone for use in the treatment of fatigue or cognitive impairment in patients with liver diseases | |
| PL4337029T3 (pl) | Suplement diety do stosowania jako środek wspomagający w zapobieganiu i leczeniu pogorszenia funkcji poznawczych związanego z chorobą alzheimera | |
| IL325508A (en) | Levodopa derivatives with fatty acids, preparations containing them, and their uses for the treatment of Parkinson's disease | |
| IL286818A (en) | Mirikizumab for use in a method of treating crohns disease | |
| SMT202500307T1 (it) | Derivati di 1-metil-1h-pirazol-3-ile per l’uso nel trattamento di malattie neovascolari | |
| ZA200703237B (en) | Pharmaceutical agents comprising blood components <10 KDA and their use for prophylaxis and treatment of defects of the immune system | |
| DE60212349D1 (de) | Verwendung von n-acetyl-d-glucosamin bei der herstellung eines pharmazeutischen mittels zur prävention und behandlung von sexuellen störungen | |
| GB202002299D0 (en) | Agents for use in the treatment of tissue damage | |
| GB202004879D0 (en) | Peptide for use in the treatment or prevention of alzheimer's disease | |
| GB2610895C (en) | Composition for use in the treatment and/or prevention of mycotoxic disease | |
| IL164763A0 (en) | Byperforin derivatives, the use thereof and formulations containing them | |
| Chierakul | Update on treatment of melioidosis | |
| IL289616A (en) | Substituted 1,3-phenyl heteroaryl derivatives and their use in the treatment of disease | |
| HUP2100070A1 (hu) | Talampanel alkalmazása Alzheimer-betegségben | |
| GB202107297D0 (en) | Composition for use in the treatment and/or prevention of mycotoxic disease | |
| GB202403191D0 (en) | Medicament and medicament combination for use in the treatment of infectious disease | |
| IL314066A (en) | Methods and compositions for treating parkinson's disease | |
| GB202304262D0 (en) | Flavonoid compound for use in the treatment of diseases and conditions associated with movement disorders |